Edition:
India

Alder Biopharmaceuticals Inc (ALDR.OQ)

ALDR.OQ on NASDAQ Stock Exchange Global Market

18.64USD
20 Sep 2019
Change (% chg)

$-0.02 (-0.11%)
Prev Close
$18.66
Open
$18.65
Day's High
$18.72
Day's Low
$18.60
Volume
1,619,957
Avg. Vol
392,336
52-wk High
$18.90
52-wk Low
$8.39

Select another date:

Mon, Sep 16 2019

Lundbeck buys Alder for $2 billion, eyes 'blockbuster' migraine therapy

COPENHAGEN Denmark's Lundbeck has agreed to buy Alder BioPharmaceuticals in a deal valued at almost $2 billion, hoping to reap profits from a potential blockbuster migraine drug.

UPDATE 2-Lundbeck buys Alder for $2 billion, eyes 'blockbuster' migraine therapy

* Hopes to close deal before end of year (Adds Lundbeck CEO comments)

Lundbeck to buy migraine treatment developer Alder BioPharmaceuticals

COPENHAGEN, Sept 16 Danish pharmaceutical company Lundbeck will acquire Alder BioPharmaceuticals in a deal valued at almost $2 billion, the company said in a statement on Monday.

Select another date: